Join to View Full Profile
2501 N. Orange AvenueOrlando, FL 32804
Phone+1 407-303-1700
Dr. Goldstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of MichiganFellowship, Hematology and Medical Oncology, 1988 - 1991
- University of MichiganInternship, Internal Medicine, 1985 - 1986
- University of Pittsburgh School of MedicineClass of 1985
Certifications & Licensure
- FL State Medical License 1994 - 2027
- MI State Medical License 1988 - 2019
- PA State Medical License 1990 - 2012
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 27 citationsThe Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research A...Jack W. Hsu, Nosha Farhadfar, Hemant S. Murthy, Brent R. Logan, Stephanie Bo-Subait
Transplantation and Cellular Therapy. 2021-03-22 - 23 citationsImpact of Next-Generation Sequencing Cell-free Pathogen DNA Test on Antimicrobial Management in Adults with Hematological Malignancies and Transplant Recipients with S...James B. Yu, Juan D. Diaz, Steven C. Goldstein, Rushang D. Patel, Juan C. Varela
Transplantation and Cellular Therapy. 2021-02-26 - 20 citationsConditioning regimen intensity and low-dose azacitidine maintenance after allogeneic hematopoietic cell transplantation for acute myeloid leukemia.Naveed Ali, Benjamin Tomlinson, Leland Metheny, Steven C. Goldstein, Pingfu Fu
Leukemia & Lymphoma. 2020-07-10
Journal Articles
- Aggressive Leukemic Non-Nodal Mantle Cell Lymphoma (L-NN-MCL) with P53 Gene Re-arrangement/Mutation Is Highly Responsive to Rituximab/Ibrutinib Combination TherapyShahram Mori, Juan Varela, Steven C Goldstein, Daniel O Persky, Clinical Lymphoma, Myeloma, & Leukemia
Authored Content
- Aggressive Leukemic Non-Nodal Mantle Cell Lymphoma (L-NN-MCL) with P53 Gene Re-arrangement/Mutation Is Highly Responsive to Rituximab/Ibrutinib Combination TherapyNovember 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: